NicholasATritosMDDSc, MMSc

Pituitary Disorders & Neuroendocrinology

Associate Professor of Medicine, Massachusetts General Hospital and Harvard Medical School

Dr. Tritos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Mass General Hospital, Neuroendocrine Unit
100 Blossom Street, Cox 1, Suite 140
Boston, MA 02114
Phone+1 617-726-7948

Fax+1 617-726-1241

Dr. Nicholas Tritos is an endocrinologist in Boston, MA and is affiliated with Massachusetts General Hospital. He received his medical degree from University of Athens and has been in practice 31 years. He specializes in pituitary disorders & neuroendocrinology and is experienced in autoimmune hypophysitis, hyperprolactinemia, acromegaly, growth hormone deficiency, and pituitary masses.

Harvard Medical SchoolMMSc, Medical Science, 2001 - 2003
Beth Israel Deaconess Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1999
Lahey ClinicFellowship, Endocrinology, Diabetes, and Metabolism, 1995 - 1996
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1992 - 1995
University of AthensClass of 1989, MD

PubMed

312 citations
Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma.
Alexander T. Faje, Ryan J. Sullivan, Donald P. Lawrence, Nicholas A. Tritos, Riley Fadden
The Journal of Clinical Endocrinology and Metabolism. 2014-07-31
90 citations
Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis.
Alexander T. Faje, Kerry L. Reynolds, Leyre Zubiri, Donald P. Lawrence, Justine V. Cohen
European Journal of Endocrinology. 2019-09-01
31 citations
Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly.
Eleanor Lin, Tamara Wexler, Lisa B. Nachtigall, Nicholas A. Tritos, Brooke Swearingen
Clinical Endocrinology. 2012-09-01

Journal Articles

Cushing's Disease in Older Patients: Presentation and Outcome
Nicholas A Tritos, Brooke Swearingen, Clinical Endocrinology
Effects of Growth Hormone Therapy on Bone Density and Fracture Risk in Age-Related Osteoporosis in the Absence of Growth Hormone Deficiency: A Systematic Review and Me...
Anne Klibanski, Nicholas A Tritos, Endocrine